One of the most critical issues in healthcare is that of medication non-adherence: only 50% of patients take their medications as prescribed, costing the healthcare system billions of dollars annually as non-adherent patients are more likely to need emergency care and result in higher treatment costs. The global medication adherence market is projected to reach $6.0 billion by 2025, with the global pandemic emphasizing the importance of medication adherence. For patients with chronic illnesses, non-adherence can make them more susceptible to contracting COVID-19, and thus result in a higher risk of adverse outcomes. Moreover, most measurements of medication adherence are based on possession rather than ingestion, an inadequate way to track dose-by-dose adherence. If our definition of adherence shifted, more patients would have their adherence accurately measured. emocha Health CEO Sebastian Seiguer states, “We must change the way we measure medication adherence in the industry to ensure we can effectively address today’s health crises.”

Read the full article in Managed Healthcare Executive